Healthcare
ResMed Inc.(RMD)
Live Price
Offline$188.63
+1.26% today
1Y Change
-24.02%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $29.87B
- Revenue Growth
- +9.8%
- EPS Growth
- +37.6%
- Dividend Yield
- 1.1%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ResMed Inc. (RMD) is a Healthcare stock with a market cap of $29.87B and listed on NYSE. The stock last traded around $188.63 and down 24.0% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +9.8%, EPS growth of +37.6%, a dividend yield of 1.1%. What stands out right now is revenue +9.8%, EPS +37.6%, free cash flow +29.2% with operating margin 34.3% and ROIC 19.6%. The dividend is present but secondary, with a yield around 1.1%. Valuation sits in the middle of the pack at P/E 19.8 and price/sales 5.4. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines RMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+9.8% vs +7.6% peer median
Operating Margin
Above sector median
+34.3% vs +19.4% peer median
P/E
Below sector median
19.8 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 30, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +9.8% and EPS at +37.6%, with operating margin around 34.3%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.1%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.2% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 30, 2026 | โ | -4.1% | -3.2% | -10.9% |
2026 Jan 29, 2026 | +2.5% | +0.3% | +3.7% | -0.5% |
2025 Oct 30, 2025 | +1.6% | -2.1% | -1.0% | +1.4% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RMD
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RMD Max Drawdown
-37.76%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RMD and SPY.
Company Overview
ResMed Inc.
New York Stock Exchange
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
- Leadership
- Michael J. Farrell
- IPO Date
- Jun 2, 1995
- Employees
- 10.0k
- Street Address
- 9001 Spectrum Center Boulevard
- Mailing
- San Diego, CA, 92123
- Region
- San Diego, CA, US
- Reporting Currency
- USD
- Investor Line
- 858 836 5000
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 19.8
- EV/EBITDA
- 13.8
- Price/Sales
- 5.4
- Price/Book
- 4.6
Growth
- Revenue
- +9.8%
- EPS
- +37.6%
- Free Cash Flow
- +29.2%
Profitability
- Gross Margin
- 61.7%
- Operating Margin
- 34.3%
- Net Margin
- 27.4%
- ROE
- 24.4%
- ROIC
- 19.6%
Balance Sheet
- Debt/Equity
- 0.13
- Current Ratio
- 3.01
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.